Article Information
History
- June 5, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Xue Han1,2,
- Wenhan Yang1,
- Xi Zhang1,2,
- Baolan Chen1,2,
- Xi Fu1,
- Jitian Huang1,2,
- Yingxia Xu1,2,
- Yajie Gong1,2,* and
- Qingsong Chen1,2,*
- 1School of Public Health, Guangdong Pharmaceutical University, Guangzhou, China
- 2NMPA Key Laboratory for Technology Research and Evaluation of Pharmacovigilance, Guangzhou, China
- ↵*Corresponding Author:
1.E-mail:qingsongchen{at}aliyun.com(QSC), 2.E-mail:gongyajie2016{at}163.com(YJG)